β-Lapachone-mediated Apoptosis in Human Promyelocytic Leukemia (HL-60) and Human Prostate Cancer Cells: A p53-independent Response

Cancer Research

Volumn 55, Issue 17, 1995, Pages 3706-3711

  Planchon, Sarah M ^a   Wuerzberger, Shelly ^a   Boothman, David A ^a   Church, Dawn R ^a   Wilding, George ^a   Frydman, Benjamin ^a   Witiak, Donald T ^a   Hutson, Paul ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LAPACHONE; CAMPTOTHECIN; GYRASE INHIBITOR; PROTEIN P53; TOPOTECAN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL POPULATION; DNA REPAIR; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME BINDING; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROSTATE CANCER;

APOPTOSIS; BREAST NEOPLASMS; CAMPTOTHECIN; CELL DIVISION; DIMETHYL SULFOXIDE; DNA TOPOISOMERASES, TYPE I; DRUG SCREENING ASSAYS, ANTITUMOR; G0 PHASE; G1 PHASE; HUMAN; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; NAPHTHOQUINONES; PROSTATIC NEOPLASMS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0028982219     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Thompson, R. H. Naturally occurring quinones. In: Napthoquinones, pp. 198–366. New York: Academic Press, 1971.
2. Docampo, R., Lopes, J. N., Cruz, F. S., and DeSouza, W. Trypanosoma cruz: ultrastructural and metabolic alterations of epimastigotes by 0-lapachone. Exp. Para-sitol., 42: 142–149, 1977.
3. Docampo, R., Cruz, F. S., Boveris, A., Muniz, R. P. A., and Esquivel, D. M. S. Lipid peroxide in β-lapachone-treated Trypanosoma cruz epimastigotes. Arch. Biochem. Biophys., 186: 292–297, 1978.
4. Boothman, D. A., Trask, D. K., and Pardee, A. B. Inhibition of potentially lethal DNA damage repair in human tumor cells by 0-lapachone, an activator of topoisomerase I. Cancer Res., 49: 605–612, 1989.
5. Boothman, D. A., Greer, S., and Pardee, A. B. Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by 0-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[l,2-b]pyran-5,6-dione), a novel DNA repair inhibitor. Cancer Res., 47: 5361–5367, 1987.
6. Boothman, D. A. Enhanced malignant transformation is accompanied by increased survival recovery following ionizing radiation. Radiat. Res., 138: 121–125, 1994.
7. Boothman, D. A., Wang, M., Schea, R., Burrows, H. L., Strickfaden, S., and Owens, J. K. Posttreatment exposure to camptothecin enhances the lethal effects of X-rays on radioresistant human malignant melanoma cells. Int. J. Radiat. Oncol. Biol. Phys., 24: 939–948, 1992.
8. Li, C. J., Averboukh, L., and Pardee, A. B. 0-Lapachone, a novel topoisomerase I inhibitor with a mode of action different from camptothecin. J. Biol. Chem., 268: 22463–22468, 1993.
9. Crespi, M. D., Mladovan, A. G., and Baldi, A. Increment of DNA topoisomerases in chemically and virally transformed cells. Exp. Cell Res., 175: 206–215, 1988.
10. Hussain, I., Mohler, J. L., Seigler, H. F., and Besterman, J. M. Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res., 54: 539–546, 1994.
11. Solary, E., Bertrand, R., Kohn, K. W., and Pommier, Y. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood, 81: 1359–1368, 1993.
12. Kamesaki, S., Kamesaki, H., Jorgensen, T. J., Tanizawa, A., Pommier, Y., and Cossman, J. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair. Cancer Res., 53: 4251–4256, 1993.
13. Hooker, S. C. The constitution of lapachic acid (lapachol) and synthesis of 0-lapa-chone. J. Chem. Soc., 611–650, 1892.
14. Hsiang, Y.-H., Hertzberg, R., Hecht, S., and Liu, L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem., 260: 14873–14878, 1985.
15. Boothman, D. A., Fukunaga, N., and Wang, M. Down-regulation of topoisomerase I in mammalian cells following ionizing radiation. Cancer Res., 54: 4618–4626, 1994.
16. Stone, K. R., Mickey, D. D., Wunderli, H., Mickey, G. H., and Paulson, D. F. Isolation of a human prostate carcinoma cell line (DU-145). Int. J. Cancer, 21: 274–281, 1978.
17. Horoszewisz, J. S., Leong, S. S., Kawinski, E., Karr, J. P., Rosenthal, H., Chu, T. M., Mirand, E. A., and Murphy, G. P. LNCaP model of human prostatic carcinoma. Cancer Res., 43: 1809–1818, 1983.
18. Rago, R., Mitchen, J., and Wilding, G. DNA fluorometric assay in 96-well tissue culture plates using Hoescht 33258 after cell lysis by freezing in distilled water. Anal. Biochem., 191: 31–34, 1990.
19. Fried, J., Perez, A. J., and Clarkson, B. D. Rapid hypotonic method for flow cytofluorometry of monolayer cell cultures: some pitfalls in staining and data analysis. J. Histochem. Cytochem., 26: 921–933, 1978.
20. Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., and Owens, J. J. T. Antibodies to CD βT-cell receptor complex induced death by apoptosis in immature T cells in thymic cultures. Nature (Lond.), 337: 181–184, 1989.
21. Li, C. J., Wang, C., and Pardee, A. B. Induction of apoptosis by 0-lapachone in human prostate cancer cells. Cancer Res., 55:3712–3715, 1995.
22. Wang, T. T. Y., and Phang, J. M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res., 55: 2487–2489, 1995.